He's long gone. Sold out after the initial pump.
salgovernale69 • Jun 4, 2015 11:13 AM Flag
users liked this posts
users disliked this posts
LOL!!!! I haven't been in either AVXL or TPIV in weeks and made well over 100% on each. TNXP is the play, I'm in for 15,000 shares at 6.65 average. Easy money I'll sell at $12 within a month.
The poster data (AAIC) was not the 3Q15 data release.
If they achieve full enrollment soon, you can expect full data from PART A of the trial to be released (late September, I suspect).
Type in AVXL for company (quote), then in the left hand column there is a short interest link.
Since it does trade on the OTC, I don't know if the info is accurate.
Your post offends them because anything even remote deemed as critical of the company or drug threatens their assertion that Anavex 2-73 cures everything and that they will all be multi-millionaires be the end of the year.
You'll be hard pressed to find any balanced information on this board.
No one said that Anavex 2-73 is a cure for AD. Not the CEO, not the lead investigator, no one who attended the AAIC conference, no one.
Enough already. Great preliminary results, that's it.
You guys sound like you work for a boiler room.
The extended phase can not end in December because they are still recruiting.
So the original planned 6 month follow up (after phase IIa, part A) will not be completed by December.
Why are people posting that Anavex 2-73 cures AD, works on Epilepsy, Parkinson's, etc. or the company will get approval after this phase II trial?
Are they sleazeball boiler room pumpers?
He stated it works without other drugs.
From their poster presentation you don't know if it works without other drugs. Most evaluated patients were taking donepezil.